Biology and therapy of mantle cell lymphoma.
作者： Michael E Williams , John J Densmore
DOI: 10.1097/01.CCO.0000174039.69656.2B
关键词:
摘要: Purpose of reviewMantle cell lymphoma is an aggressive non-Hodgkin's characterized by the t(11;14) chromosomal translocation and overexpression cyclin D1. Constituting approximately 5 to 8% all lymphomas, it carries poorest prognosis among subt
sci-hub.se 参考文章(30)
Francesco Bertoni, Emanuele Zucca, Finbarr E. Cotter, Molecular basis of mantle cell lymphoma British Journal of Haematology. ,vol. 124, pp. 130- 140 ,(2004) , 10.1046/J.1365-2141.2003.04761.X
Francesco Bertoni, Annarita Conconi, Sergio B. Cogliatti, Shu-Fang Hsu Schmitz, Michele Ghielmini, Thomas Cerny, Martin Fey, Gabriella Pichert, Francesco Bertolini, Maurilio Ponzoni, Luca Baldini, Chris Jones, Rebecca Auer, Emanuele Zucca, Franco Cavalli, Finbarr E. Cotter, , Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research British Journal of Haematology. ,vol. 124, pp. 289- 298 ,(2004) , 10.1046/J.1365-2141.2003.04763.X
John J. Densmore, Michael E. Williams, Mantle cell lymphoma. Current Treatment Options in Oncology. ,vol. 4, pp. 281- 287 ,(2000) , 10.1007/S11864-003-0003-1
Orion M Howard, John G Gribben, Donna S Neuberg, Michael Grossbard, Christina Poor, Milos J Janicek, Margaret A Shipp, Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival Journal of Clinical Oncology. ,vol. 20, pp. 1288- 1294 ,(2002) , 10.1200/JCO.20.5.1288
Gavin Babbage, Richard Garand, Nelly Robillard, Niklas Zojer, Freda K. Stevenson, Surinder S. Sahota, Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood. ,vol. 103, pp. 2795- 2798 ,(2004) , 10.1182/BLOOD-2003-05-1632
Hannes Kaufmann, Markus Raderer, Stefan Wöhrer, Andreas Püspök, Alexander Bankier, Christoph Zielinski, Andreas Chott, Johannes Drach, Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma. Blood. ,vol. 104, pp. 2269- 2271 ,(2004) , 10.1182/BLOOD-2004-03-1091
Eric Jacobsen, Arnold Freedman, An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma. Current Opinion in Oncology. ,vol. 16, pp. 106- 113 ,(2004) , 10.1097/00001622-200403000-00004
Hiroyuki Tagawa, Sivasundaram Karnan, Ritsuro Suzuki, Keitaro Matsuo, Xiaohua Zhang, Akinobu Ota, Yasuo Morishima, Shigeo Nakamura, Masao Seto, Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene. ,vol. 24, pp. 1348- 1358 ,(2005) , 10.1038/SJ.ONC.1208300
Steven H. Swerdlow, Michael E. Williams, From centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades Human Pathology. ,vol. 33, pp. 7- 20 ,(2002) , 10.1053/HUPA.2002.30221
M. Jermann, L.M. Jost, Ch. Taverna, E. Jacky, H.P. Honegger, D.C. Betticher, F. Egli, Th. Kroner, R.A. Stahel, Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study Annals of Oncology. ,vol. 15, pp. 511- 516 ,(2004) , 10.1093/ANNONC/MDH093